Menu
Back to Journals » Clinical Ophthalmology » Volume 7
Intravitreal anti-VEGF injection for the treatment of progressive juxtapapillary retinal capillary hemangioma: a case report and mini review of the literature
Authors Chelala E, Dirani A , Fadlallah A
Received 19 August 2013
Accepted for publication 10 September 2013
Published 31 October 2013 Volume 2013:7 Pages 2143—2146
DOI https://doi.org/10.2147/OPTH.S53243
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Elias Chelala, Ali Dirani, Ali Fadlallah
Saint-Joseph University, Faculty of Medicine, Beirut, Lebanon
Abstract: We report a case of a patient known to have a von Hippel–Lindau disease with documented progressive juxtapapillary retinal capillary hemangioma (JRCH) with well-preserved visual acuity (VA) and visual field (VF). The patient received a single injection of intravitreal ranibizumab (IVR). Six months after IVR injection, the JRCH showed reduced vascularization, fibrosis, and mild shrinkage, and VA and VF remained unchanged. IVR therapy might therefore be considered as an alternative treatment for progressive JRCH, especially in patients with well-preserved VA and VF.
Keywords: juxtapapillary retinal capillary hemangioma, intravitreal anti-VEGF injection, von Hippel–Lindau disease
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.